Use of recombinant feline interferon and glucocorticoid in the treatment of feline infectious peritonitis

J Feline Med Surg. 2004 Apr;6(2):107-9. doi: 10.1016/j.jfms.2003.08.011.

Abstract

A total of 12 clinically ill cats previously diagnosed as feline infectious peritonitis (FIP) were treated with a combination of recombinant feline interferon and glucocorticoid. A complete remission (over 2 years) and a partial remission (2 to 5 months) were observed in four (33.3%) and four (33.3%) cases, respectively. Those that survived for more than 2 years were all older cats (6 to 16 years old) with the effusive form of FIP.

Publication types

  • Evaluation Study

MeSH terms

  • Animals
  • Cats
  • Drug Therapy, Combination
  • Feline Infectious Peritonitis / drug therapy*
  • Female
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use*
  • Interferons / administration & dosage
  • Interferons / therapeutic use*
  • Male
  • Recombinant Proteins
  • Treatment Outcome

Substances

  • Glucocorticoids
  • Recombinant Proteins
  • Interferons